The role of KNSTRN in tumors involves the promotion of tumorigenesis and gemcitabine resistance through the activation of AKT (also known as protein kinase B) in bladder cancers (Xiong et al. 2021). This evidence concerns the gene KNSTRN and urinary bladder carcinoma.